Cancer Treatment Drugs
-
{
- All
- News
- Videos
-
Rs 10 Crore Fake Medicine Racket Busted In Delhi, 4 Arrested
- Thursday May 7, 2026
- Health | Reported by Mukesh Singh Sengar
The gang specialized in faking high-stakes treatments for cancer, liver disease, and other critical illnesses, putting countless lives at risk across the country.
-
www.ndtv.com
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
- Monday April 20, 2026
- Health | Indo Asian Service News
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
www.ndtv.com
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
- Saturday April 18, 2026
- Health | Written by Debosmita Ghosh
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
- Friday April 3, 2026
- Health | Written by Sambhav Kumar
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
www.ndtv.com
-
Medical Breakthrough: Scientists Awarded 1 Million Pounds For Life-Saving Brain Cancer Gel
- Wednesday March 25, 2026
- Health | Press Trust of India
UK scientists awarded £1m to develop smart gel using plasma tech, offering new hope for brain cancer, skin disease and fungal infection treatments.
-
www.ndtv.com
-
What Is Imfinzi Durvalumab, The Cancer Drug That Just Got Approval For Use In India?
- Wednesday February 11, 2026
- Health | Written by Varsha Vats
Unlike traditional chemotherapy, which attacks rapidly dividing cells (both healthy and cancerous), Durvalumab helps your own immune system recognise and destroy cancer cells. It targets a specific protein called PD-L1.
-
www.ndtv.com
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
Tax Cuts On Cancer Drugs, Higher Tobacco Tax Can Boost Public Health: AIIMS Study
- Thursday February 5, 2026
- Health | Indo-Asian News Service
The Goods and Services Tax (GST) exemption of lifesaving cancer drugs and higher taxation on tobacco products are the steps aimed at strengthening public health in the country, according to a new study led by oncologists from
-
www.ndtv.com
-
India's Fight Against Cancer Gets Stronger With Ayushman Arogya Mandir: JP Nadda
- Wednesday February 4, 2026
- Health | Indo-Asian News Service
Ayushman Arogya Mandirs is strengthening the fight against cancer in India, said Union Health Minister JP Nadda on World Cancer Day on Wednesday.
-
www.ndtv.com
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
- Monday February 2, 2026
- Health | Written by Shreya Goswami
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
www.ndtv.com
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
- Sunday February 1, 2026
- Health | Written by Shreya Goswami
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
www.ndtv.com
-
Scientists Cure Pancreatic Cancer In Mice Without Major Side Effects
- Thursday January 29, 2026
- Feature | Edited by Abhinav Singh
Scientists achieved pancreatic cancer tumour disappearance in mice using a triple combination therapy, paving the way for future clinical trials.
-
www.ndtv.com
-
Rs 10 Crore Fake Medicine Racket Busted In Delhi, 4 Arrested
- Thursday May 7, 2026
- Health | Reported by Mukesh Singh Sengar
The gang specialized in faking high-stakes treatments for cancer, liver disease, and other critical illnesses, putting countless lives at risk across the country.
-
www.ndtv.com
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
- Monday April 20, 2026
- Health | Indo Asian Service News
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
www.ndtv.com
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
- Saturday April 18, 2026
- Health | Written by Debosmita Ghosh
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
- Friday April 3, 2026
- Health | Written by Sambhav Kumar
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
www.ndtv.com
-
Medical Breakthrough: Scientists Awarded 1 Million Pounds For Life-Saving Brain Cancer Gel
- Wednesday March 25, 2026
- Health | Press Trust of India
UK scientists awarded £1m to develop smart gel using plasma tech, offering new hope for brain cancer, skin disease and fungal infection treatments.
-
www.ndtv.com
-
What Is Imfinzi Durvalumab, The Cancer Drug That Just Got Approval For Use In India?
- Wednesday February 11, 2026
- Health | Written by Varsha Vats
Unlike traditional chemotherapy, which attacks rapidly dividing cells (both healthy and cancerous), Durvalumab helps your own immune system recognise and destroy cancer cells. It targets a specific protein called PD-L1.
-
www.ndtv.com
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
Tax Cuts On Cancer Drugs, Higher Tobacco Tax Can Boost Public Health: AIIMS Study
- Thursday February 5, 2026
- Health | Indo-Asian News Service
The Goods and Services Tax (GST) exemption of lifesaving cancer drugs and higher taxation on tobacco products are the steps aimed at strengthening public health in the country, according to a new study led by oncologists from
-
www.ndtv.com
-
India's Fight Against Cancer Gets Stronger With Ayushman Arogya Mandir: JP Nadda
- Wednesday February 4, 2026
- Health | Indo-Asian News Service
Ayushman Arogya Mandirs is strengthening the fight against cancer in India, said Union Health Minister JP Nadda on World Cancer Day on Wednesday.
-
www.ndtv.com
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
- Monday February 2, 2026
- Health | Written by Shreya Goswami
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
www.ndtv.com
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
- Sunday February 1, 2026
- Health | Written by Shreya Goswami
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
www.ndtv.com
-
Scientists Cure Pancreatic Cancer In Mice Without Major Side Effects
- Thursday January 29, 2026
- Feature | Edited by Abhinav Singh
Scientists achieved pancreatic cancer tumour disappearance in mice using a triple combination therapy, paving the way for future clinical trials.
-
www.ndtv.com